<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01218854</url>
  </required_header>
  <id_info>
    <org_study_id>100217</org_study_id>
    <secondary_id>10-CC-0217</secondary_id>
    <nct_id>NCT01218854</nct_id>
  </id_info>
  <brief_title>A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy</brief_title>
  <official_title>A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institutes of Health Clinical Center (CC)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      - Currently, standard procedures for biopsies that are guided by computed tomography (CT)&#xD;
      imaging involve CT scans and a computer program to plan and illustrate where the physician&#xD;
      will place the needle to obtain the required cells or tissue. Inserting the biopsy needle at&#xD;
      the planned angle is not an easy task, because the appropriate angle of insertion must be&#xD;
      estimated based on prior experience. Researchers are studying experimental techniques that&#xD;
      might provide better guidance about the right angle to insert the biopsy needle and thereby&#xD;
      improve the collection of the appropriate biopsy cells or tissue.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      - To evaluate the effectiveness of two biopsy needle guidance methods in CT-guided tissue&#xD;
      biopsy.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      - Individuals at least 18 years of age who are scheduled to have CT-guided tissue biopsy.&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  Participants will have a tissue biopsy guided by CT scans and either a laser system or a&#xD;
           plastic block to illustrate the appropriate angle of insertion. The skin will be numbed&#xD;
           with anesthetic to minimize discomfort during the procedure.&#xD;
&#xD;
        -  Before inserting the biopsy needle, the study physician will hold the needle in place so&#xD;
           that a Food and Drug Administration-approved medical GPS (electromagnetic tracking)&#xD;
           system can measure the needle angle as it enters the tissue.&#xD;
&#xD;
        -  After the needle angle data has been collected, researchers will proceed with the actual&#xD;
           biopsy procedure as it would normally occur, using standard methods.&#xD;
&#xD;
        -  No additional treatment will be provided as part of this protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
        -  Currently, standard/conventional CT-guided biopsies proceed as follows the physician:&#xD;
&#xD;
             1. obtains a pre-procedural CT scan,&#xD;
&#xD;
             2. plans the needle s angle based on this CT scan,&#xD;
&#xD;
             3. selects the angle at which the needle should be inserted based on the&#xD;
                pre-procedural CT scan,&#xD;
&#xD;
             4. inserts the needle while aiming to replicate that planned needle angle by using&#xD;
                only their visual-spatial abilities, and&#xD;
&#xD;
             5. re-images the patient to confirm needle location followed by needle&#xD;
&#xD;
                repositioning, if needed.&#xD;
&#xD;
        -  Improving upon these standard methods of needle placement could have&#xD;
&#xD;
      widespread benefits (e.g. improved diagnostic tissue sampling, decreased&#xD;
&#xD;
      needle repositionings, etc.) We will be studying three needle angle selection systems. The&#xD;
      laser-assisted needle angle selection system or LNASS, is a custom fabricated device that&#xD;
      uses a Class II pointer similar to ones used for pointing at slides during lectures.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        -  To compare the angle difference between L-NASS (Method A) and the standard method&#xD;
           (clinician intuition/conventional method)&#xD;
&#xD;
        -  To compare the angle difference between B-NASS (Method B) and the standard method&#xD;
           (clinician intuition)&#xD;
&#xD;
        -  To compare the angle difference between the mobile device-NASS or MD-NASS (C) and the&#xD;
           standard method (clinician intuition/conventional method)&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
        -  Ages Eligible for Study: 18 Years and older&#xD;
&#xD;
        -  Genders Eligible for Study: Both&#xD;
&#xD;
        -  Inclusion:&#xD;
&#xD;
             -  Must be undergoing a scheduled CT-guided biopsy.&#xD;
&#xD;
             -  Must have ability to follow breathing instructions like holding breath (if&#xD;
                procedure is to be performed without general anesthesia).&#xD;
&#xD;
        -  Exclusion:&#xD;
&#xD;
        -  No serious concurrent medical illness that would preclude the patient from making a&#xD;
           rational informed decision on participation.&#xD;
&#xD;
        -  Any known allergy to plastics or polymers (since the Ultem polymer could theoretically&#xD;
           induce a rash in these patients, even though it is hypoallergenic).&#xD;
&#xD;
        -  Pacemakers or automatic implantable cardiac defibrillators.&#xD;
&#xD;
        -  Gross body weight above the CT table limit (450 pounds).&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  Primary outcome measure for the first arm is:&#xD;
&#xD;
           --The difference between planned and achieved needle angle of a laser-assisted needle&#xD;
           angle selection system with the standard method (clinician s intuition or conventional&#xD;
           method) of CT-guided biopsy.&#xD;
&#xD;
        -  Primary outcome measure for the second arm is:&#xD;
&#xD;
           --The difference between planned and achieved needle angle of a block with pre-drilled&#xD;
           needle angles with the standard method (clinician s intuition or conventional method) of&#xD;
           CT-guided biopsy&#xD;
&#xD;
        -  Primary outcome for the third arm is:&#xD;
&#xD;
           --The difference between planned and achieved needle angle of a mobile device-assisted&#xD;
           needle angle selection system with the standard method (clinician's intuition or&#xD;
           conventional method) of CT-guided biopsy.&#xD;
&#xD;
        -  The tool for measuring the needle angles will be an FDA-approved electromagnetic&#xD;
           tracking system, which tracks needle movement and position.&#xD;
&#xD;
        -  These comparisons will be done as a bystander study.&#xD;
&#xD;
        -  Needle guidance system will only be used initially to select the angle during a&#xD;
           superficial, shallow needle insertion at the skin surface (less than 1 cm deep).&#xD;
&#xD;
        -  At no time will the needle enter tissue that it wouldn t have otherwise entered as none&#xD;
           of the system will be used to perform the biopsies at this time.&#xD;
&#xD;
        -  The key portions of the procedure will not be altered in any substantive way.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2012</start_date>
  <completion_date type="Actual">November 16, 2016</completion_date>
  <primary_completion_date type="Actual">November 16, 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference between L-NASS and standard method</measure>
    <time_frame>Completion of study</time_frame>
    <description>Data is currently undergoing analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differnce between B-NASS and standard method</measure>
    <time_frame>Completion of study</time_frame>
    <description>Data is currently undergoing analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The difference between MD-NASS and standard method</measure>
    <time_frame>Completion of study</time_frame>
    <description>Data is currently undergoing analysis</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Liver Neoplasms</condition>
  <condition>Kidney Neoplasms</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>B-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Block assisted needle angle selection system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laser assisted needle angle selection system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MD-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mobile-device assisted needle angle selection system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Needle angle measurement</intervention_name>
    <description>The tool for measuring the needle angles will be an FDA-approved EM tracking system. At no time will the needle enter tissue that it wouldn t have otherwise entered as neither system will be used to perform the biopsies at this time.</description>
    <arm_group_label>B-NASS</arm_group_label>
    <arm_group_label>L-NASS</arm_group_label>
    <arm_group_label>MD-NASS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        Patients must fulfill all of the following criteria to be eligible for study admission:&#xD;
&#xD;
          -  All patients must be undergoing a CT-guided biopsy.&#xD;
&#xD;
          -  Age greater than 18 years.&#xD;
&#xD;
          -  No serious concurrent medical illness that would preclude the patient from making a&#xD;
             rational informed decision on participation.&#xD;
&#xD;
          -  The ability to understand and willingness to sign a written informed consent form, and&#xD;
             to comply with the protocol. If in question, an ethics consult will be obtained.&#xD;
&#xD;
          -  Ability to follow breathing instructions like holding breath (if procedure is to be&#xD;
             performed without general anesthesia).&#xD;
&#xD;
          -  Patients must be actively enrolled on an NIH protocol and be scheduled for a CT-guided&#xD;
             biopsy.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          -  Patients with an altered mental status that precludes understanding or consenting for&#xD;
             the biopsy procedure will be excluded from this study.&#xD;
&#xD;
          -  Patients unlikely to be able to hold reasonably still on a procedure table for the&#xD;
             length of the procedure.&#xD;
&#xD;
          -  Patients with any known allergy to plastics or polymers (since the Ultem -polymer&#xD;
             could theoretically induce a rash in these patients, even though it is&#xD;
             hypoallergenic).&#xD;
&#xD;
          -  Inability to follow breathing instructions, if without general anesthesia.&#xD;
&#xD;
          -  Patients with pacemakers or automatic implantable cardiac defibrillators.&#xD;
&#xD;
          -  Gross body weight above the CT table limit (450 pounds).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradford J Wood, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institutes of Health Clinical Center (CC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2010-CC-0217.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Miaux Y, Guermazi A, Gossot D, Bourrier P, Angoulvant D, Khairoune A, Turki C, Bouch√© E. Laser guidance system for CT-guided procedures. Radiology. 1995 Jan;194(1):282-4.</citation>
    <PMID>7997570</PMID>
  </reference>
  <reference>
    <citation>Pereles FS, Baker M, Baldwin R, Krupinski E, Unger EC. Accuracy of CT biopsy: laser guidance versus conventional freehand techniques. Acad Radiol. 1998 Nov;5(11):766-70.</citation>
    <PMID>9809074</PMID>
  </reference>
  <reference>
    <citation>Jacobi V, Thalhammer A, Kirchner J. Value of a laser guidance system for CT interventions: a phantom study. Eur Radiol. 1999;9(1):137-40.</citation>
    <PMID>9933397</PMID>
  </reference>
  <verification_date>August 5, 2021</verification_date>
  <study_first_submitted>October 8, 2010</study_first_submitted>
  <study_first_submitted_qc>October 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2010</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Surgical Navigation</keyword>
  <keyword>Image-guided Therapy</keyword>
  <keyword>CT- Guided Biopsy</keyword>
  <keyword>Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

